Thelansis

 Renal cell carcinoma (RCC), which accounts for approximately 80% to 90% of kidney cancers, is a malignancy that originates in the renal parenchyma or cortex. The precise cause of RCC remains unknown. Several factors can increase the risk of developing renal cancer, such as advancing age, obesity, hypertension, chronic renal failure, undergoing dialysis treatment, having polycystic kidney disease, belonging to the African American race, suffering from sickle cell disease, or having a history of renal stones. Additionally, certain hereditary conditions can also elevate the risk of RCC, including tuberous sclerosis, Von Hippel-Lindau syndrome, Birt-Hogg-Dube syndrome, hereditary papillary renal carcinoma, and hereditary leiomyomatosis and renal cell carcinoma (HLRCC). Treatment approaches for RCC vary depending on the stage of the tumor. When considering the differential diagnosis of other solid renal tumors, it's essential to consider conditions like renal oncocytoma, lipid-poor ren...